The Latest Headlines at ETF Daily News
Skillsoft (NASDAQ:SKIL) Stock Price Down 3.2%
Skillsoft Corp. (NASDAQ:SKIL – Get Free Report)’s stock price fell 3.2% during mid-day trading on Monday . The stock traded as low as $8.60 and last traded at $8.60. 33,492 shares changed hands during trading, a decline... More of this article »
AAR (NYSE:AIR) Earns “Outperform” Rating from Royal Bank of Canada
Royal Bank of Canada reissued their outperform rating on shares of AAR (NYSE:AIR – Free Report) in a research report report published on Friday morning, Benzinga reports. The brokerage currently has a $80.00 price objective... More of this article »
HC Wainwright Reaffirms Buy Rating for Genprex (NASDAQ:GNPX)
Genprex (NASDAQ:GNPX – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at HC Wainwright in a report issued on Monday, Marketbeat reports. They currently have a $10.00 price target... More of this article »
Humacyte (NASDAQ:HUMA) Receives Buy Rating from Benchmark
Benchmark reiterated their buy rating on shares of Humacyte (NASDAQ:HUMA – Free Report) in a report published on Monday, Benzinga reports. They currently have a $15.00 price target on the stock. Separately, HC Wainwright assumed... More of this article »
Organovo (NASDAQ:ONVO) Coverage Initiated by Analysts at StockNews.com
StockNews.com started coverage on shares of Organovo (NASDAQ:ONVO – Free Report) in a report released on Monday. The firm issued a sell rating on the medical research company’s stock. Organovo Trading Up 1.0 % ONVO stock... More of this article »
LiqTech International (NASDAQ:LIQT) Receives New Coverage from Analysts at StockNews.com
StockNews.com initiated coverage on shares of LiqTech International (NASDAQ:LIQT – Free Report) in a report issued on Monday. The firm issued a sell rating on the stock. Separately, Ascendiant Capital Markets assumed coverage... More of this article »
IRIDEX (NASDAQ:IRIX) Receives New Coverage from Analysts at StockNews.com
StockNews.com started coverage on shares of IRIDEX (NASDAQ:IRIX – Free Report) in a research note released on Monday morning. The brokerage issued a hold rating on the medical equipment provider’s stock. IRIDEX Trading... More of this article »
Lyra Therapeutics (NASDAQ:LYRA) Price Target Cut to $11.00 by Analysts at Bank of America
Lyra Therapeutics (NASDAQ:LYRA – Free Report) had its price target trimmed by Bank of America from $12.00 to $11.00 in a research report released on Monday, Benzinga reports. The brokerage currently has a buy rating on the stock. LYRA... More of this article »
Lifetime Brands (NASDAQ:LCUT) Price Target Raised to $11.50 at DA Davidson
Lifetime Brands (NASDAQ:LCUT – Free Report) had its price objective upped by DA Davidson from $9.50 to $11.50 in a research report released on Monday, Benzinga reports. DA Davidson currently has a buy rating on the stock. A number... More of this article »
High Tide’s (HITI) “Buy” Rating Reaffirmed at Roth Mkm
Roth Mkm reissued their buy rating on shares of High Tide (NASDAQ:HITI – Free Report) in a report released on Monday, Benzinga reports. Roth Mkm currently has a $4.50 price target on the stock. Separately, TheStreet raised High... More of this article »
Magnite (NASDAQ:MGNI) Receives “Buy” Rating from Benchmark
Benchmark reaffirmed their buy rating on shares of Magnite (NASDAQ:MGNI – Free Report) in a report released on Monday morning, Benzinga reports. They currently have a $18.00 price target on the stock. Several other analysts... More of this article »
Kinetik (NASDAQ:KNTK) Now Covered by Analysts at Royal Bank of Canada
Royal Bank of Canada initiated coverage on shares of Kinetik (NASDAQ:KNTK – Free Report) in a report issued on Monday, Marketbeat Ratings reports. The firm issued an outperform rating and a $40.00 price objective on the stock. KNTK... More of this article »
ImmunoGen (NASDAQ:IMGN) Research Coverage Started at StockNews.com
StockNews.com started coverage on shares of ImmunoGen (NASDAQ:IMGN – Free Report) in a research note issued to investors on Monday. The firm issued a hold rating on the biotechnology company’s stock. A number of other brokerages... More of this article »